VEA
JNCE
Virtus ETF Advisers’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-58,867
| Closed | -$1.32M | – | 277 |
|
|
2018
Q1 | $1.32M | Buy |
58,867
+31,919
| +118% | +$714K | 1.14% | 12 |
|
|
2017
Q4 | $344K | Buy |
26,948
+6,650
| +33% | +$84.9K | 0.43% | 100 |
|
|
2017
Q3 | $316K | Buy |
20,298
+1,856
| +10% | +$28.9K | 0.04% | 129 |
|
|
2017
Q2 | $259K | Buy |
+18,442
| New | +$259K | 0.04% | 140 |
|